Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04138381
Title Selinexor as a Single Agent and in Combination With Imatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors. (SeliGIST)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Grupo Espanol de Investigacion en Sarcomas

gastrointestinal stromal tumor


Imatinib + Selinexor

Age Groups: senior | adult
Covered Countries ESP

No variant requirements are available.